Imfinzi (durvalumab) - AstraZeneca
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Keytruda (pembrolizumab) - Merck (MSD)
https://app.dgt26mz.smart-abstract.com/sm-events/day/event/120485/123604
 
Ö. Okumus1; H. Kaman1; T. Stork1; E.L. Buchmeier2; C. Groß-Ophoff-Müller2; T.P.H. Köster3; W. Windisch4; S. Collaud1
 
Sep 9, 2026
 
Prev Next